Define the need
Clarify the disease area, research or clinical question, sample conditions, timing and key stakeholders.
NovoBay works with diagnostics and pharmaceutical companies to advance market expansion, clinical collaboration, partner development and commercialization, starting from product stage, evidence conditions and target markets.
Every project starts with enterprise goals and application needs. We first clarify product stage, target market, practical constraints and decision points, then organize suitable clinical, industry and commercial resources.
Assess priority opportunities, key stakeholders and phased market-entry pathways based on product attributes, evidence status, target markets and commercial goals.
Connect suitable hospitals, experts and research teams to assess research questions, collaboration conditions, validation resources and project-launch arrangements.
Connect pharmaceutical companies, diagnostics providers and specialist resources around biomarker, patient-stratification and testing needs to shape collaborative solutions.
Map the channel ecosystem, identify prospective business partners and advance discussions with priority institutions according to product stage and target market.
NovoBay focuses on the points where work can break down between defining a need and executing a collaboration, rather than on a one-time introduction.
Clarify the disease area, research or clinical question, sample conditions, timing and key stakeholders.
Evaluate partner technology, evidence, boundaries, resource conditions and the project's stage.
Define scope, validation plans, responsibility interfaces, decision points and communication mechanisms.
Coordinate resources and feedback, identify execution barriers and support later translation or commercial discussions.
Specific deliverables depend on the project's objectives and written collaboration arrangements, and typically fall into three groups.
Build a common view of the target scenario, unmet need, potential partners and priorities.
Map candidate technologies, sample and workflow requirements, and evidence that still needs to be verified or generated.
Clarify accountable parties, key milestones, collaboration boundaries and the conditions for moving forward.
Tell us about the research, clinical or commercialization scenario you are evaluating.